Kevan Herold, MD

Professor of Immunobiology and of Medicine (Endocrinology); Deputy Director, Yale Center for Clinical Investigation; Director, Yale Diabetes Center

Clinical Interests

  • Diabetes Mellitus, Type 1

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From patients or physicians

Patient Care Organizations

Internal Medicine: Diabetes Research Center | Endocrinology: Diabetes Center

Clinical Investigation, Yale Center for (YCCI)

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Internal Medicine AB of Internal Medicine (1982)

  • Endocrinology & Metabolism AB of Internal Medicine (1985)

Clinical Trials

Conditions Study Title
Children's Health, Diabetes Mellitus - Type 1 Type 1 Diabetes Extension Study (T1DES)
Diabetes Mellitus - Type 1, Diseases of the Endocrine System, Immune System Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)
Diabetes Mellitus - Type 1, Pregnancy, Childbirth and the Puerperium Beta Cell Dynamics of Women with Type I Diabetes During Pregnancy
Children's Health, Diabetes Mellitus - Type 1, Diseases of the Endocrine System ATG-GCSF in New Onset Type 1 Diabetes
Children's Health, Diseases of the Endocrine System, Genetics - Adult, Genetics - Pediatric, Mental Health & Behavioral Research Specimen and Data Repository
Children's Health, Diabetes Mellitus - Type 1, Diseases of the Endocrine System Pathway to Prevention
Diabetes Mellitus - Type 1, Diseases of the Endocrine System A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Children's Health, Diabetes Mellitus - Type 1, Diseases of the Endocrine System CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Children's Health, Diabetes Mellitus - Type 1, Diseases of the Endocrine System Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"

Edit this profile